Clinical Trial Update: A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathies (DEE) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial to evaluate LP352 for developmental and epileptic encephalopathy in children and adults is currently recruiting. The study is sponsored…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Developmental and Epileptic Encephalopathy

Drugs mentioned

• LP352

Snippet

Sponsor: Longboard Pharmaceuticals | Conditions: Developmental and Epileptic Encephalopathy | Phase 3 | Status: RECRUITING